Related Experiment Video
Updated: Jul 19, 2026
09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
[CD8+ cytotoxic lymphocytes in cutaneous leishmaniasis]
Joselín Hernández-Ruiz1, Ingeborg Becker
1Departamento de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de Mexico, México, DF. hernandezjoselin@yahoo.com.mx
Salud Publica De Mexico
|October 27, 2006
Summary
CD8+ T cells are crucial in fighting Leishmania parasites causing cutaneous leishmaniasis. Understanding their activation mechanisms, possibly involving dendritic cells, could reveal new therapeutic strategies for this neglected tropical disease.
Area of Science:
- Immunology
- Parasitology
- Cellular Biology
Context:
- Cutaneous leishmaniasis is a significant global health concern caused by Leishmania species.
- While other immune cells like macrophages, dendritic cells, CD4 T cells, and NK cells are well-studied, the role of CD8+ T cells remains less understood.
- Existing research, primarily from murine models, indicates CD8+ T cells contribute through Interferon-gamma (IFN-γ) production and potentially cytotoxic activity, as observed in human cases.
Purpose:
- To review the current literature on the function of CD8+ T cells in the immune response against Leishmania species responsible for cutaneous leishmaniasis.
- To highlight the knowledge gaps concerning CD8+ T T cell involvement and activation pathways in leishmaniasis.
- To explore potential mechanisms of CD8+ T cell activation, such as antigen presentation by dendritic cells.
Summary:
- CD8+ T cells play a vital role in the immune defense against Leishmania parasites.
- Both IFN-γ production and cytotoxic functions of CD8+ T cells are implicated in controlling cutaneous leishmaniasis.
- The precise mechanisms of CD8+ T cell activation in this disease are not fully elucidated but may involve dendritic cell-mediated antigen presentation.
Impact:
- A deeper understanding of CD8+ T cell roles can illuminate the physiopathology of leishmaniasis.
- This knowledge may pave the way for novel therapeutic interventions and treatment strategies for cutaneous leishmaniasis.
- Identifying key activation pathways could lead to targeted immunotherapies to enhance protective immunity.
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...